CeraVe Facial Moisturising Lotion With SPF 30 52ml
£15.50
Here’s why you’ll love Once Product:
- We’re trusted – with over 65,000 Trustpilot reviews and an ‘Excellent’ rating
- We verify all of our sellers – you can shop millions of products with confidence
- Easy payments – all major credit cards accepted, as well as PayPal
A daily lightweight facial moisturiser with SPF30 and 3 Essential Ceramides. Offers broad spectrum UVA/UVB protection, hydrates skin for up to 24 hours & helps restore skin barrier function.
CeraVe AM Facial Moisturising Lotion SPF30 is a lightweight moisturiser is suitable for all skin types and can be applied on the face daily. Enriched with SPF30 and 3 Essential Ceramides, this moisturising lotion offers broad spectrum protection against UVA/UVB rays, preserves moisture for up to 24 hours and helps restore skin barrier function. Also suitable for sensitive skin
INGREDIENTS:
- This daily moisturiser contains 3 Essential Ceramides, Niacinamide and Hyaluronic Acid.
- Formulated with patented MVE Technology, this moisturiser delivers instant & long-lasting hydration.
BENEFITS:
DEVELOPED WITH DERMATOLOGISTS
- Dr Ifeoma Ejikeme, Skin Consultant
- All CeraVe products have been Developed with Dermatologists.
- 94% of UK Dermatologists recommend CeraVe*
KEY BENEFITS
- Protects against broad spectrum UVA/UVB rays with SPF30, in line with expert recommendation: “I recommend wearing factor 50 every day and a minimum of factor 30”
- Continuous hydration for up to 24 hours
- Improves skin barrier function in 1 hour
- Lightweight formula, non-greasy or sticky
- Non-comedogenic. Allergy tested.
- 89% agree product absorbs quickly
- 94% agree skin feels healthier
- ^Instrumental test on 25 subjects. ^^131 & ^^^139 of 149 participants agree.
HOW TO USE:
- After cleansing, use pump applicator to dispense product onto fingertips, or directly onto skin
- Apply liberally to face and neck in the morning.
- Avoid contact with eyes. If contact occurs rinse thoroughly with water.












Reviews
There are no reviews yet.